0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Antibodies > Trastuzumab > Anti-Trastuzumab Antibodies (recommended for PK/PD)

Anti-Trastuzumab Antibodies (recommended for PK/PD)

  • Source
    Anti-Trastuzumab Antibodies (recommended for PK/PD) (TRB-Y5b) is expressed from human 293 cells (HEK293).
  • Isotype
    IgG1/kappa
  • Specificity
    Recognizes Trastuzumab specifically, no cross reactivity with other humanized antibodies.
  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    No activity loss was observed after storage at:

    1. 4-8°C for 12 months in lyophilized state;

    2. -70°C for 3 years under sterile conditions after reconstitution.

SDS-PAGE
Anti-Trastuzumab Antibodies (recommended for PK/PD) (Cat. No. TRB-Y5b) SDS-PAGE gel

Anti-Trastuzumab Antibodies (recommended for PK/PD) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.

Bioactivity-ELISA
Anti-Trastuzumab Antibodies (recommended for PK/PD)Anti-Trastuzumab Antibodies (recommended for PK/PD) (Cat. No. TRB-Y5b) ELISA bioactivity

Immobilized Trastuzumab at 1 μg/mL (100 μL/well) can bind Anti-Trastuzumab Antibodies (recommended for PK/PD) (Cat. No. TRB-Y5b) with a linear range of 0.19-6.25 ng/mL.

  • Background
    Trastuzumab, is a monoclonal antibody used to treat breast cancer. Specifically it is used for breast cancer that is HER2 receptor positive. Trastuzumab works by binding to the HER2 receptor and slowing down cell duplication. Trastuzumab is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein.
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

Comments (0)

Order Details

Price(USD) : $300.00

Price(USD) : $1980.00

Promotion & Exhibitions

  • PEGS Boston 2019
  • PepTalk 2019

Datasheet & Documentation

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Questions & Comments

This web search service is supported by Google Inc.

totop